<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7423511\results\search\disease\results.xml">
  <result pre="italic;} Int J Infect DisInt. J. Infect. DisInternational Journal of" exact="Infectious" post="Diseases1201-97121878-3511The Authors. Published by Elsevier Ltd on behalf of"/>
  <result pre="Published by Elsevier Ltd on behalf of International Society for" exact="Infectious" post="Diseases. pmcid: 7423511S1201-9712(20)30656-1 doi: 10.1016/j.ijid.2020.08.027 : Perspective Translation of"/>
  <result pre="7423511S1201-9712(20)30656-1 doi: 10.1016/j.ijid.2020.08.027 : Perspective Translation of genomic epidemiology of" exact="infectious" post="pathogens: Enhancing African genomics hubs for outbreaks ObohMary Aigbiremoaâ�ŽOmolekeSemeeh"/>
  <result pre=": Perspective Translation of genomic epidemiology of infectious pathogens: Enhancing" exact="African" post="genomics hubs for outbreaks ObohMary Aigbiremoaâ�ŽOmolekeSemeeh AkinwalebAjibolaOlumideacMannehJarraaKantehAbdoulieaSesayAbdul-KarimaAmambua-NgwaAlfreda[a], [b], [c],"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="hubs across the continent. â€¢To ensure sustainability and regional ownership," exact="African" post="governments should be key players. Abstract Background Deadly emerging"/>
  <result pre="African governments should be key players. Abstract Background Deadly emerging" exact="infectious" post="pathogens pose an unprecedented challenge to health systems and"/>
  <result pre="approaches against these pathogens, including Ebola and the novel coronavirus" exact="disease" post="2019 (COVID-19). Discussion Africa has contributed few genomes of"/>
  <result pre="2019 (COVID-19). Discussion Africa has contributed few genomes of severe" exact="acute" post="respiratory syndrome-coronavirus 2 (SARS-CoV-2) to the global pool in"/>
  <result pre="(COVID-19). Discussion Africa has contributed few genomes of severe acute" exact="respiratory" post="syndrome-coronavirus 2 (SARS-CoV-2) to the global pool in growing"/>
  <result pre="access repositories. To bridge this gap, the Africa Centre for" exact="Disease" post="Control and Prevention (ACDC) is coordinating continent-wide initiatives to"/>
  <result pre="coordinating continent-wide initiatives to establish genomic hubs in selected well-resourced" exact="African" post="centres of excellence. This will allow for standardisation and"/>
  <result pre="approaches to be taken at central genomic hubs. Conclusion The" exact="ACDC" post="needs to scale-up its campaign for government support across"/>
  <result pre="ACDC needs to scale-up its campaign for government support across" exact="African" post="Union countries to ensure the sustainable financing of its"/>
  <result pre="and inevitable future epidemics in Africa. Keywords COVID-19 Africa GISAID" exact="ACDC" post="Genomic hubs Brief introduction of COVID-19 situation The novel"/>
  <result pre="Genomic hubs Brief introduction of COVID-19 situation The novel coronavirus" exact="disease" post="2019 (COVID-19), a viral outbreak caused by the severe"/>
  <result pre="of COVID-19 situation The novel coronavirus disease 2019 (COVID-19), a" exact="viral" post="outbreak caused by the severe acute respiratory syndrome-coronavirus 2"/>
  <result pre="disease 2019 (COVID-19), a viral outbreak caused by the severe" exact="acute" post="respiratory syndrome-coronavirus 2 (SARS-CoV-2), first arose in Wuhan, China,"/>
  <result pre="2019 (COVID-19), a viral outbreak caused by the severe acute" exact="respiratory" post="syndrome-coronavirus 2 (SARS-CoV-2), first arose in Wuhan, China, in"/>
  <result pre="August 3, 2020, 17,660,523 cases had been detected, with 680,894" exact="total" post="deaths globally. Africa has borne 4.5% of global morbidity"/>
  <result pre="of all affected countries, with a projected serious impact on" exact="African" post="countries that are already saddled with weak health care"/>
  <result pre="containment strategies, and this requires obtaining genomic data by sequencing" exact="viral" post="isolates from infected persons. The use of high-throughput next-generation"/>
  <result pre="and transmission studies. As the virus continues to evolve in" exact="African" post="populations, African countries and the Africa Centre for Disease"/>
  <result pre="studies. As the virus continues to evolve in African populations," exact="African" post="countries and the Africa Centre for Disease Control and"/>
  <result pre="in African populations, African countries and the Africa Centre for" exact="Disease" post="Control and Prevention (ACDC) must facilitate investment in costly"/>
  <result pre="in Africa are included in the design of new interventions." exact="African" post="SARS-CoV-2 genomes in publicly available sequence databases While SARS-CoV-2"/>
  <result pre="COVID-19 outbreaks within the continent. This is primarily due to" exact="limited" post="skillsets and infrastructural deficiencies (Devex, 2020). To the present,"/>
  <result pre="To the present, only 900 SARS-CoV-2 genome sequences from 14" exact="African" post="countries have been uploaded out of a total of"/>
  <result pre="from 14 African countries have been uploaded out of a" exact="total" post="of 62,267 whole-genome sequences in GISAID (GISAID, 2020), an"/>
  <result pre="(GISAID, 2020), an online database for the rapid sharing of" exact="viral" post="genomes and clinical and epidemiological data. Africa has recorded"/>
  <result pre="2020a). On a global scale, this significantly outweighs the available" exact="African" post="SARS-CoV-2 genomes, putting the continent at disadvantage in global"/>
  <result pre="detection and diagnostics with sequencing technologies. The transition to sequencing" exact="viral" post="genomes could adopt cost-effective, easily deployable and portable sequencing"/>
  <result pre="restrict movement and curb the spread of the infection. If" exact="viral" post="sequencing platforms are not available in a country, it"/>
  <result pre="real-time contributions to global sequencing challenging and unrealistic. Therefore, while" exact="ACDC" post="aims for a coordinated, centralised approach to high-throughput next-generation"/>
  <result pre="2018, Gilbert et al., 2020). Unlike in the global North," exact="African" post="capacities are heterogeneous, with wide differences between most sub-Saharan"/>
  <result pre="African capacities are heterogeneous, with wide differences between most sub-Saharan" exact="African" post="countries and South Africa, for example. Moreover, research activities"/>
  <result pre="driven by lack of political will and buy-in by various" exact="African" post="governments, which continue to consider investments in advanced scientific"/>
  <result pre="scientific technologies as low priority despite the large burden of" exact="infectious diseases." post="The cost of acquiring and maintaining new technologies such"/>
  <result pre="al., 2017). At the moment, direct budgeting and investment by" exact="African" post="governments in medical research remains minimal, despite the pledge"/>
  <result pre="minimal, despite the pledge signed by all countries in the" exact="African" post="Union to commit 2% GDP to investment in research,"/>
  <result pre="GDP to investment in research, under the auspices of the" exact="ACDC" post="designated body for coordinating disease control across the continent."/>
  <result pre="under the auspices of the ACDC designated body for coordinating" exact="disease" post="control across the continent. Beyond data-generating platforms, there is"/>
  <result pre="across the continent. Beyond data-generating platforms, there is also an" exact="acute" post="shortage of expertise in genetic and genomic data analysis"/>
  <result pre="research collaborators and donor funding from the global North for" exact="limited" post="quality and few valid data outputs. Hence, the benefit"/>
  <result pre="are changing the narrative. These have been largely funded by" exact="external" post="donors, including the NIH, World Bank, Wellcome Trust and"/>
  <result pre="donors, including the NIH, World Bank, Wellcome Trust and the" exact="African" post="Academy of Science. Taking West Africa as an example,"/>
  <result pre="at London School of Hygiene and Tropical Medicine (MRCG-LSHTM); West" exact="African" post="Centre for Cell Biology and Infectious Disease Pathogens (WACCBIP),"/>
  <result pre="Tropical Medicine (MRCG-LSHTM); West African Centre for Cell Biology and" exact="Infectious" post="Disease Pathogens (WACCBIP), University of Ghana; Institute Pasteur Dakar,"/>
  <result pre="Medicine (MRCG-LSHTM); West African Centre for Cell Biology and Infectious" exact="Disease" post="Pathogens (WACCBIP), University of Ghana; Institute Pasteur Dakar, Senegal;"/>
  <result pre="Disease Pathogens (WACCBIP), University of Ghana; Institute Pasteur Dakar, Senegal;" exact="Malaria" post="Research and Training Center (MRTC), Mali; The African Center"/>
  <result pre="Dakar, Senegal; Malaria Research and Training Center (MRTC), Mali; The" exact="African" post="Center of Excellence in Genomics of Infectious Pathogens (ACEGIP),"/>
  <result pre="(MRTC), Mali; The African Center of Excellence in Genomics of" exact="Infectious" post="Pathogens (ACEGIP), Nigeria. In Central Africa, genomics centres are"/>
  <result pre="of Excellence in Genomics of Infectious Pathogens (ACEGIP), Nigeria. In" exact="Central" post="Africa, genomics centres are almost entirely absent, with the"/>
  <result pre="building momentum for advanced molecular bioscience research in West and" exact="Central" post="Africa. Emerging coordination and networking of genomics and testing"/>
  <result pre="Emerging coordination and networking of genomics and testing hubs The" exact="ACDC" post="has taken up a coordinated continental perspective to define"/>
  <result pre="in equipment, software and reagents to the region through the" exact="ACDC" post="(Devex, 2020). Recently, the African Union Commission/ACDC formally launched"/>
  <result pre="to the region through the ACDC (Devex, 2020). Recently, the" exact="African" post="Union Commission/ACDC formally launched the Partnership to Accelerate COVID-19"/>
  <result pre="workers across the continent, establish a central procurement system at" exact="ACDC" post="and deploy one million community health workers to perform"/>
  <result pre="impact of its interventions might not be manifest in the" exact="short" post="term. However, the ACDC, as a new institution, could"/>
  <result pre="experience of already established centres such as the European and" exact="American" post="CDCs to put into place regulation and structures that"/>
  <result pre="the near future. Conclusion and recommendations Despite the efforts of" exact="ACDC" post="to promote centralised genomic hubs, a situational analysis of"/>
  <result pre="Ebola virus (EBOV) during the last outbreak in West and" exact="Central" post="Africa (Arias et al., 2016, Hoenen et al., 2016,"/>
  <result pre="comparative data analysis. To build on its current gains, the" exact="ACDC" post="should engage in a massive campaign for stronger political"/>
  <result pre="should engage in a massive campaign for stronger political commitment" exact="African" post="Union member states to support funding for genomics as"/>
  <result pre="genomics as a tool for the surveillance and monitoring of" exact="disease" post="outbreaks. Better engagement approaches will enable government buy-in and"/>
  <result pre="sustainability of established genomics institutions for rapid containment of emerging" exact="infectious disease" post="epidemics. Funding source This perspective did not receive any"/>
  <result pre="of established genomics institutions for rapid containment of emerging infectious" exact="disease" post="epidemics. Funding source This perspective did not receive any"/>
  <result pre="from: www.genomicsengland.co.uk [cited 17 June 2020] GilbertM.PullanoG.PinottiF.ValdanoE.PolettoC.BoÃ«lleP.Y.Preparedness and vulnerability of" exact="African" post="countries against importations of COVID-19: a modelling studyLancet39510227202087187732087820 GISAIDGISAID20208[Internet]."/>
  <result pre="for virus origins and receptor bindingLancet [Internet]39510224202056557410.1016/S0140-6736(20)30251-8 OmolekeS.A.AjibolaO.AjiboyeJ.O.RajiR.O.Quagmire of epidemic" exact="disease" post="outbreaks reporting in NigeriaBMJ Glob Heal32018e000659 QuickJ.LomanN.J.DuraffourS.SimpsonJ.T.SeveriE.CowleyL.Real-time, portable genome"/>
  <result pre="treatment of patients with advanced cancersMol Genet Genomic Med53201725126028546995 WHOCoronavirus" exact="disease" post="2019 situation report 195202020 WHOStatement on the second meeting"/>
  <result pre="2020]. WHO/AfricaWHO ramps up preparedness for novel coronavirus in the" exact="African" post="region2020[Internet]. Available from: https://www.afro.who.int/news/who-ramps-preparedness-novel-coronavirus-african-region ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients"/>
  <result pre="region2020[Internet]. Available from: https://www.afro.who.int/news/who-ramps-preparedness-novel-coronavirus-african-region ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med3828202072773331978945 Acknowledgement This idea"/>
 </snippets>
</snippetsTree>
